Zymeworks Inc. · NASDAQ:ZYME
Schayowitz Adam sold 13,832 Zymeworks Inc. shares (Form 4)
Traded Oct 9, 2026 · Filed Oct 9, 2026
On Oct 9, 2026, Schayowitz Adam (EVP, Head of R&D) sold 13,832 Zymeworks Inc. shares at US$25.85 for US$358K, leaving 23,205 shares. Filed Oct 9, 2026 (Form 4).
- Sold
- 13,832 shares
- Price
- US$25.85
- Value
- US$358K
- Holding after
- 23,205 shares
- Trading plan
- No
- Role
- EVP, Head of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Common Stock | Option exercise | 37,037 | 37,037 | Direct | |
| Oct 9, 2026 | Common Stock | Sale | 13,832 | US$25.85 | 23,205 | Direct |
Source
Related
- Zymeworks Inc.
- Schayowitz Adam
- Zymeworks Inc. shareholders
- Form 4 · Hollywood Mark · Jul 6, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G · Perceptive Advisors LLC · Apr 15, 2026
- Schedule 13G/A · Rubric Capital Management LP · Feb 13, 2026
- Schedule 13G/A · Morgan Stanley · Feb 12, 2026